浸润性导管癌

体视学在乳腺浸润性导管癌中的应用

Application of stereology in breast invasive ductal carcinoma

浸润性导管癌的阳性表达率（71.15%）明显高于导管内癌局部浸润的阳性表达率（30.00%）（P

Expression rate in invasive ductal carcinoma ( 71.15 % ) was obviously higher than local invasive ductal carcinoma in situ ( 30.00 % )( P

乳腺浸润性导管癌DNA图像分析

DNA image analysis of vessel soaked in breast carcinoma

目的探讨DNA含量与乳腺浸润性导管癌组织学分级的关系。

Objective To study the correlation between the histological grading and DNA aneuploidy .

钼靶CR对浸润性导管癌的诊断价值肉芽肿性乳腺炎的数字钼靶X线表现

The Diagnostic Value of Infiltrated Mammo-ductal Carcinoma by Molybdenum Target X-ray

乳腺浸润性导管癌患者手术前后血浆VEGF的变化及其意义

Change of plasma VEGF levels in breast invasive ductal carcinomas and its significance

Bcl-2和Bax表达在乳腺浸润性导管癌细胞凋亡中的作用

Expression of Bcl-2 and Bax on Apoptosis in Breast Invasive Ductal Carcinoma

结果：乳腺浸润性导管癌中各病理分级之间的DNA含量和倍体的差异有显著性（P<0.05）。

Results : Pathologic grading in vessel soaked in breast carcinoma correlated with DNA content and chromosome a ploidy ( P < 0.05 ) .

乳腺浸润性导管癌bcl-2、bax基因蛋白表达与预后的关系

Expression and prognostic value of bcl-2 and bax gene protein in breast invasive ductal carcinoma

乳腺浸润性导管癌p53蛋白、增殖细胞核抗原表达与预后的关系

The expression and prognostic value of p53 and proliferating cell nuclear antigen in breast invasive ductal carcinoma

乳腺浸润性导管癌中Survivin表达及其与ERPR的相关性研究

The Related Research of the Expression of Survivin and ER PR in Ductal Infiltrated Breast Carcinoma

乳腺浸润性导管癌超声征象与病理组织学分级及ER、PR表达的相关性研究

Correlation Ultrasonographic Features and the Expression of ER , PR , Pathologic Histology Grading in Breast Invasive Ductal Carcinoma Between

分析乳腺浸润性导管癌（IDC）的声像图特征，提高超声对IDC的诊断价值。

Objective To analyze sonographic characteristics of infiltrative ductal carcinoma ( IDC ) .

Ⅰ、Ⅱ和Ⅲ级浸润性导管癌中ER基因的甲基化阳性率分别为0%，43%，82%（p＜0.05）；

The methylation-positive rates of grade ⅰ、ⅱ and ⅲ breast cancer were respectively 0 % , 43 % , 82 % ( p ﹤ 0.05 ) for ER .

Ets-1、VEGF在乳腺浸润性导管癌组织的表达及其临床意义

Expression of Ets-1 and VEGF in breast invasive ductal carcinoma and its clinical significance

方法用端粒酶重复扩增法（TRAP）检测了61例乳腺浸润性导管癌及14例乳腺良性病变组织端粒酶活性。

Method Telomerase activity was detected in 61 cases of infiltration ductal carcinomas of breast and 14 cases of benign changed breast using TRAP assay .

结论：TSP可能具有促进乳腺细胞增殖的作用，对乳腺浸润性导管癌的发生发展转移影响不大。

Conclusions : TSP maybe promote proliferation of breast cells but not influence occurrence , development and metastasis of invasive ductal carcinoma .

乳腺浸润性导管癌中pS2基因表达的意义

PS 2 protein expression in breast cancer and its significance

目的观察谷胱甘肽-硫-转移酶（GST-π）和肿瘤抑癌基因产物P53蛋白在乳腺浸润性导管癌组织中的表达并探讨其临床意义。

Objective To observe the expression of glutathione S transferase π( GST - π) and P ~ ( 53 ) in infiltrating ductal breast carcinoma and their clinical significance .

方法：将39例乳腺浸润性导管癌进行Feulgen染色，然后用图像分析系统进行DNA含量和倍体测定。

Methods : 39 cases of vessel soaked in breast carcinoma were stained by Feulgen method , and then analyzed using color image analysis system .

目的研究P53蛋白，增殖细胞抗原（PCNA），bcl2，bax基因蛋白在乳腺浸润性导管癌中表达的相关性及预后的关系。

Objective To investigate the correlation between the expressions of P53 ? PCNA ﹑ bvl-2 and bax and the prognosis of infiltrative ductal breast cancer .

乳腺浸润性导管癌中p57~（kip2）、cyClinD1和CyclinE的表达及意义

Expression of p57 ~ ( kip2 ), cyclin D1 , and cyclin E and their clinical significances in invasive duct carcinomas of the breast

浸润性导管癌中15%出现cyClinD1基因扩增，35%出现cyClinD1mRNA表达升高。

The amplification rate of cyclin D1 gene in breast carcinoma was 15 % and the high expression of cyclin D1 mRNA was 35 % .

结果CD105的表达在乳腺浸润性导管癌明显高于乳腺导管内癌及乳腺良性增生组织（P值均<0.01）。

Results The expression level of CD_ 105 in breast infiltrating duct cancer was significantly higher than that in breast duct cancer and benign hyperplasisa ( P < 0.01 ) .

结果乳腺浸润性导管癌标本的GSTπ的阳性表达率为72.1%；

Results The positive rate of GST - π was 72.1 % and P ~ ( 53 ) was 67.4 % in infiltrating ductal breast carcinoma .

乳腺浸润性导管癌患者血清HIF-1α和Gly-G含量的变化及其意义

Changes of serum HIF-1 α and Gly-G in patients with invasive ductal breast cancer

结论：P27蛋白、ER受体表达及淋巴结转移情况对乳腺浸润性导管癌的预后分析有重要参考价值。

Conclusions : The expression of P27-protein , ER receptor and lymph node metastasis have important value on predicting the prognosis in patients with invasive breast carcinoma .

乳腺浸润性导管癌及其腋窝转移淋巴结中CCR5的表达变化及意义

Changes and significance of chemokine receptor 5 in breast invasive ductal carcinoma and metastatic axillary nodes

CD105和CD34标记的MVD在浸润性导管癌中有显著性差异（P<0.01）；

There was a statistical significance in MVD marked by CD105 and CD34 in cases with breast infiltrative duct cancer ( P < 0.01 ), too .

不同组织学类型TAM抑制率实验似有差异，髓样癌的阳性检出率较浸润性导管癌高。

The TAM positive rate in medullary cancer was higher than that in other pathologic types of breast tumors and it was the lowest in ductal cancers .